Showing results (931-940 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|May 25, 2016
Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracyR M Zur, L M Roy, S Ito, et al.
The Pharmacogenomics Journal|May 12, 2016
Prenatal pharmacogenomics: a promising area for researchE H Dorfman, E Y Cheng, M F Hebert, et al.
The Pharmacogenomics Journal|June 1, 2016
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapyM Frías, D Rodríguez-Cano, F Cuenca-López, et al.
The Pharmacogenomics Journal|June 1, 2016
The pharmacogenomics of osteosarcomaM Serra, C M Hattinger
The Pharmacogenomics Journal|June 9, 2016
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genesS Mas, P Gassó, A Lafuente, et al.
The Pharmacogenomics Journal|September 10, 2014
Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazideJ L Del-Aguila, R M Cooper-DeHoff, A B Chapman, et al.
The Pharmacogenomics Journal|November 19, 2014
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemiaY Tanaka, A Manabe, H Fukushima, et al.
The Pharmacogenomics Journal|November 12, 2014
Quality control metrics improve repeatability and reproducibility of single-nucleotide variants derived from whole-genome sequencingW Zhang, V Soika, J Meehan, et al.
The Pharmacogenomics Journal|March 2, 2016
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancerM Gusella, S Giacopuzzi, L Bertolaso, et al.
The Pharmacogenomics Journal|February 24, 2016
Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetesA Blasetti, C Di Giulio, S Tumini, et al.
Pageof 135